Business ❯Finance ❯Corporate Finance

Pharmaceuticals

Eli Lilly Merck & Co Inc Novo Nordisk Novartis Pfizer GSK Merck AstraZeneca Amylyx Pharmaceuticals AbbVie Merck & Co. BioSyent Inc. Sanofi

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

AstraZeneca Reports Strong 2024 Results While Facing China Tax Probe

Merck Stock Declines After Weak 2025 Guidance Despite Strong Q4 Results

Merck Cuts 2025 Revenue Forecast After Halting Gardasil Shipments to China

AbbVie Reports Strong Sales Growth for Skyrizi and Rinvoq, Boosts 2027 Revenue Outlook

Novo Nordisk Expands Wegovy Supply Amid Compounding Drug Concerns

Merck's Q3 Earnings Exceed Expectations Despite Gardasil Sales Slump in China

Next Surpasses £1 Billion Profit Milestone Amid Strong Autumn Sales

Pfizer's Strong Q3 Earnings Challenge Activist Investor's Push for Change